Ikonisys SA
No trades
−0.2370 EUR
−3.24 M EUR
1.01 M EUR
About Ikonisys SA
Sector
Industry
CEO
Mario P. Crovetto
Website
Headquarters
Paris
Founded
2021
Identifiers
2
ISINFR00140048X2
Ikonisys SA specializes in the design, manufacture, and distribution of cellular diagnosis applications for cancer, genetic diseases, and fertility problems. Its products include Ikoniscope Robotic Microscope, oncoFISH bladder, oncoFISH her2, oncoFISH ALK, oncoFISH PTEN, IkoniWAN Gateway, and Ikonisoft explorer CS. The company was founded by Michael W. Kilpatrick on May 31, 2021 and is headquartered in Paris, France.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Ikonisys SA stocks are traded under the ticker 9W8.
Yes, you can track Ikonisys SA financials in yearly and quarterly reports right on TradingView.
9W8 net income for the last half-year is −1.02 M EUR, while the previous report showed −1.84 M EUR of net income which accounts for 44.51% change. Track more Ikonisys SA financial stats to get the full picture.
No, 9W8 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 2, 2026, the company has 15 employees. See our rating of the largest employees — is Ikonisys SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ikonisys SA EBITDA is −1.34 M EUR, and current EBITDA margin is −174.15%. See more stats in Ikonisys SA financial statements.
Like other stocks, 9W8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ikonisys SA stock right from TradingView charts — choose your broker and connect to your account.